Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Insight Molecular Diagnostics Inc. | 10,586 | reported | 11 Dec 2020 | tx 4+414,586 |
| Zynerba Pharmaceuticals, Inc. | 0 | reported | 10 Oct 2023 | tx 12+526,495−526,495 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Oct 2023 | GRANT_AWARD | Zynerba Pharmaceuticals, Inc. | 85,000 | — | |
| 10 Oct 2023 | TENDER | Zynerba Pharmaceuticals, Inc. | 278,333 | — | |
| 10 Oct 2023 | TENDER | Zynerba Pharmaceuticals, Inc. | 33,685 | — | |
| 10 Oct 2023 | OTHER | Zynerba Pharmaceuticals, Inc. | 200,000 | — | deriv |
| 15 Feb 2023 | SALE | Zynerba Pharmaceuticals, Inc. | 3,173 | 0.54 USD | |
| 08 Feb 2023 | TAX_WITHHOLDING | Zynerba Pharmaceuticals, Inc. | 5,463 | 0.60 USD | |
| 07 Feb 2023 | GRANT_AWARD | Zynerba Pharmaceuticals, Inc. | 18,864 | — | |
| 01 Feb 2023 | TAX_WITHHOLDING | Zynerba Pharmaceuticals, Inc. | 5,841 | 0.60 USD | |
| 31 Jan 2023 | GRANT_AWARD | Zynerba Pharmaceuticals, Inc. | 17,631 | — | |
| 24 Jan 2023 | GRANT_AWARD | Zynerba Pharmaceuticals, Inc. | 170,000 | 0.00 USD | |
| 14 Feb 2022 | GRANT_AWARD | Zynerba Pharmaceuticals, Inc. | 35,000 | 0.00 USD | |
| 14 Feb 2022 | GRANT_AWARD | Zynerba Pharmaceuticals, Inc. | 200,000 | 0.00 USD | deriv |
| 11 Dec 2020 | GRANT_AWARD | Insight Molecular Diagnostics Inc. | 5,586 | — | |
| 03 Aug 2020 | PURCHASE | Insight Molecular Diagnostics Inc. | 5,000 | 1.33 USD | |
| 10 Feb 2020 | GRANT_AWARD | Insight Molecular Diagnostics Inc. | 204,000 | 0.00 USD | deriv |
| 14 Mar 2019 | GRANT_AWARD | Insight Molecular Diagnostics Inc. | 200,000 | 0.00 USD | deriv |